Brain Neurotherapy Bio, Inc.
Clinical trials sponsored by Brain Neurotherapy Bio, Inc., explained in plain language.
-
Doctors test gene therapy to protect brain cells in Parkinson's patients
Disease control OngoingThis early-stage study is testing the safety of a new gene therapy for Parkinson's disease. Researchers are delivering a gene called GDNF directly into a specific brain region in 11 participants to see if it can protect the cells that produce dopamine. The main goal is to check f…
Phase: PHASE1 • Sponsor: Brain Neurotherapy Bio, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Brain gene therapy tested for devastating neurological disease
Disease control OngoingThis is a very early-stage safety study testing a new gene therapy for multiple system atrophy (MSA), a rare and progressive brain disorder. The therapy, called AAV2-GDNF, is delivered directly into a part of the brain called the putamen. The main goal is to see if the treatment …
Phase: PHASE1 • Sponsor: Brain Neurotherapy Bio, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC